Advertisement
Research ArticleCardiovascular

Triiodothyronine Reduces Vascular Dysfunction Associated with Hypertension by Attenuating Protein Kinase G/Vasodilator-Stimulated Phosphoprotein Signaling

Maria Alicia Carrillo-Sepulveda, Anjali Panackal, Renjith Maracheril, Nicole Maddie, Mitul N. Patel, Kaie Ojamaa, Olga V. Savinova and A. Martin Gerdes
Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 88-94; DOI: https://doi.org/10.1124/jpet.119.260471
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Research ArticleCardiovascular

Triiodothyronine Reduces Hypertensive Vascular Dysfunction

Maria Alicia Carrillo-Sepulveda, Anjali Panackal, Renjith Maracheril, Nicole Maddie, Mitul N. Patel, Kaie Ojamaa, Olga V. Savinova and A. Martin Gerdes
Journal of Pharmacology and Experimental Therapeutics October 1, 2019, 371 (1) 88-94; DOI: https://doi.org/10.1124/jpet.119.260471
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section